In an effort to support global initiatives to contain the spread of the new coronavirus (COVID-19), the Academy is moving to an online platform or postponing all meetings and events intended to be held in person through April 30, 2020. Please check here for more information, including Academy programs on COVID-19, and links to the latest advisories from public health officials.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.


Immunology of Diabetes II

Edited by Edited by C.B. Sanjeevi (Center for Molecular Medicine, Karolinska Institute, Stockholm, Sweden) and G.S. Eisenbarth (University of Colorado Health Sciences Center, Denver, CO)
Immunology of Diabetes II

Published: November 2003

Volume 1005

Learn More

This volume covers aspects of Type 1 diabetes with respect to genetic susceptibility, environmental triggers, antigen/MHC interaction, and events leading to beta cell death as well as ways to prevent the disease and novel methods of treatment. Advances in these areas will be discussed as will the standardization of different protocols carried out on behalf of the Immunology of Diabetes Society.